References
- Wensvoort G, Terpstra C, Pol JM, et al. Mystery swine disease in the Netherlands: the isolation of Lelystad virus. Vet Quart. 1991;13(3):121–130.
- Collins JE, Benfield DA, Christianson WT, et al. Isolation of swine infertility and respiratory syndrome virus (isolate ATCC VR-2332) in North America and experimental reproduction of the disease in gnotobiotic pigs. J Vet Diagn Invest. 1992;4(2):117–126.
- Kappes MA, Faaberg KS. PRRSV structure, replication and recombination: origin of phenotype and genotype diversity. Virology. 2015;479–480:475–486.
- Calvert JG, Slade DE, Shields SL, et al. CD163 expression confers susceptibility to porcine reproductive and respiratory syndrome viruses. J Virol. 2007;81(14):7371–7379.
- Whitworth KM, Rowland RRR, Ewen CL, et al. Gene-edited pigs are protected from porcine reproductive and respiratory syndrome virus. Nat Biotechnol. 2016;34(1):20–22.
- Wells KD, Bardot R, Whitworth KM, et al. Replacement of porcine CD163 scavenger receptor cysteine-rich domain 5 with a CD163-like homolog confers resistance of pigs to genotype 1 but not genotype 2 porcine reproductive and respiratory syndrome virus. J Virol. 2017;91(2):e01521–16
- Yang H, Zhang J, Zhang X, et al. CD163 knockout pigs are fully resistant to highly pathogenic porcine reproductive and respiratory syndrome virus. Antiviral Res. 2018;151:63–70.
- Prather RS, Wells KD, Whitworth KM, et al. Knockout of maternal CD163 protects fetuses from infection with porcine reproductive and respiratory syndrome virus (PRRSV). Sci Rep. 2017;7(1):13371.
- Park K-W, Cheong H-T, Lai L, et al. Production of nuclear transfer-derived swine that express the enhanced green fluorescent protein. Anim Biotechnol. 2001;12(2):173–181.
- Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339(6121):819–823.
- Mali P, Yang L, Esvelt KM, et al. RNA-guided human genome engineering via Cas9. Science. 2013;339(6121):823–826.
- Whitworth KM, Lee K, Benne JA, et al. Use of the CRISPR/Cas9 system to produce genetically engineered pigs from in vitro-derived oocytes and embryos. Biol Reprod. 2014;91(3):78.
- Burkard C, Lillico SG, Reid E, et al. Precision engineering for PRRSV resistance in pigs: Macrophages from genome edited pigs lacking CD163 SRCR5 domain are fully resistant to both PRRSV genotypes while maintaining biological function. PLoS Pathog. 2017;13(2):e1006206.
- Fan N, Lai L. Genetically modified pig models for human diseases. J Genet Genomics. 2013;40(2):67–73.
- Tanihara F, Takemoto T, Kitagawa E, et al. Somatic cell reprogramming-free generation of genetically modified pigs. Sci Adv. 2016;2(9):e1600803.
- Tanihara F, Hirata M, Nguyen NT, et al. Generation of a TP53-modified porcine cancer model by CRISPR/Cas9-mediated gene modification in porcine zygotes via electroporation. PloS One. 2018;13(10):e0206360.
- Do LT, Luu VV, Morita Y, et al. Astaxanthin present in the maturation medium reduces negative effects of heat shock on the developmental competence of porcine oocytes. Reprod Biol. 2015;15(2):86–93.
- Onishi A, Iwamoto M, Akita T, et al. Pig cloning by microinjection of fetal fibroblast nuclei. Science. 2000;289(5482):1188–1190.
- Brinkman EK, Chen T, Amendola M, van Steensel B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 2014;42(22):e168.
- Naito Y, Hino K, Bono H, Ui-Tei K. CRISPRdirect: Software for designing CRISPR/Cas guide RNA with reduced off-target sites. Bioinformatics. 2015;31(7):1120–1123.
- Tanihara F, Hirata M, Nguyen NT, et al. Generation of PDX-1 mutant porcine blastocysts by introducing CRISPR/Cas9-system into porcine zygotes via electroporation. Anim Sci J. 2019;90(1):55–61.
- Wang T, Wei JJ, Sabatini DM, Lander ES. Genetic screens in human cells using the CRISPR-Cas9 system. Science. 2014;343(6166):80–84.
- Anderson EM, Haupt A, Schiel JA, et al. Systematic analysis of CRISPR-Cas9 mismatch tolerance reveals low levels of off-target activity. J. Biotechnol. 2015;211:56–65.
- Cradick TJ, Qiu P, Lee CM, Fine EJ, Bao G. COSMID: a web-based tool for identifying and validating CRISPR/Cas off-target sites. Mol Ther Nucleic Acids. 2014;3:e214.
- Alvarez J, Sarradell J, Morrison R, Perez A. Impact of porcine epidemic diarrhea on performance of growing pigs. PLoS One. 2015;10(3):e0120532.
- Beltran-Alcrudo D, Falco JR, Raizman E, Dietze K. Transboundary spread of pig diseases: the role of international trade and travel. BMC Vet Res. 2019;15(1):64.
- Costard S, Wieland B, de Glanville W, et al. African swine fever: how can global spread be prevented? Phil Trans R Soc B. 2009;364(1530):2683–2696.
- Li BX, Ge JW, Li YJ. Porcine aminopeptidase N is a functional receptor for the PEDV coronavirus. Virology. 2007;365(1):166–172.
- Nam E, Lee C. Contribution of the porcine aminopeptidase N (CD13) receptor density to porcine epidemic diarrhea virus infection. Vet Microbiol. 2010;144(1-2):41–50.
- Delmas B, Gelfi J, L'Haridon R, et al. Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature. 1992;357(6377):417–420.
- Wang G, Wang Y, Shang Y, Zhang Z, Liu X. How foot-and-mouth disease virus receptor mediates foot-and-mouth disease virus infection. Virol J. 2015;12(1):9.
- Shirato K, Maejima M, Islam MT, et al. Porcine aminopeptidase N is not a cellular receptor of porcine epidemic diarrhea virus, but promotes its infectivity via aminopeptidase activity. J Gen Virol. 2016;97(10):2528–2539.
- Li W, Luo R, He Q, van Kuppeveld FJM, Rottier PJM, Bosch BJ. Aminopeptidase N is not required for porcine epidemic diarrhea virus cell entry. Virus Res. 2017;235:6–13.
- Whitworth KM, Rowland RRR, Petrovan V, et al. Resistance to coronavirus infection in amino peptidase N-deficient pigs. Transgenic Res. 2019;28(1):21–32.
- Zhang J, Wu Z, Yang H. Aminopeptidase N knockout pigs are not resistant to porcine epidemic diarrhea virus infection. Virol Sin. 2019. doi:10.1007/s12250-019-00127-y
- Sanchez-Torres C, Gomez-Puertas P, Gomez-del-Moral M, et al. Expression of porcine CD163 on monocytes/macrophages correlates with permissiveness to African swine fever infection. Arch Virol. 2003;148(12):2307–2323.
- Popescu L, Gaudreault NN, Whitworth KM, et al. Genetically edited pigs lacking CD163 show no resistance following infection with the African swine fever virus isolate, Georgia 2007/1. Virology. 2017;501:102–106.
- Miao D, Giassetti MI, Ciccarelli M, Lopez-Biladeau B, Oatley JM. Simplified pipelines for genetic engineering of mammalian embryos by CRISPR-Cas9 electroporation dagger. Biol Reprod. 2019;101(1):177–187.